SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001493152-24-051814 from Tharimmune, Inc. (THAR) (CIK 0001861657) (THAR)

Tharimmune, Inc. (THAR) (CIK 0001861657)
Date: Dec. 23, 2024 · CIK: 0001861657 · Accession: 0001493152-24-051814

Offering / Registration Process

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-283936

Date
Dec. 23, 2024
Author
Chief
Form
CORRESP
Company
Tharimmune, Inc. (THAR) (CIK 0001861657)

Letter

Tharimmune, Inc.

Route 22 East, Suite 2000

Bridgewater, NJ 08807

December 23, 2024

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention: Tim Buchmiller

Re:

Tharimmune, Inc.

Registration Statement on Form S-3

File No. 333-283936

Filed December 19, 2024

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), Tharimmune, Inc. (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 4:00 p.m., Eastern Standard Time, on Thursday, December 26, 2024, or as soon thereafter as possible. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.

Please notify Jeffrey Fessler of Sheppard Mullin Richter & Hampton LLP, counsel to the Company, at (212) 634-3067 as soon as possible as to the time the registration statement has been declared effective pursuant to this acceleration request.

Very
truly yours,
THARIMMUNE,
INC.

Show Raw Text
CORRESP
1
filename1.htm

Tharimmune,
Inc.

1200
Route 22 East, Suite 2000

Bridgewater,
NJ 08807

December
23, 2024

VIA
EDGAR

United
States Securities and Exchange Commission

Division
of Corporation Finance

100 F Street, N.E.

Washington,
D.C. 20549

Attention:
Tim Buchmiller

    Re:

    Tharimmune,
    Inc.

    Registration
    Statement on Form S-3

    File
    No. 333-283936

    Filed
    December 19, 2024

Ladies
and Gentlemen:

Pursuant
to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), Tharimmune, Inc.
(the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated
so that it will become effective at 4:00 p.m., Eastern Standard Time, on Thursday, December 26, 2024, or as soon thereafter as possible.
In making this acceleration request, the Company acknowledges that it is aware of its responsibilities
under the Act.

Please
notify Jeffrey Fessler of Sheppard Mullin Richter & Hampton LLP, counsel to the Company, at (212) 634-3067 as soon as possible as
to the time the registration statement has been declared effective pursuant to this acceleration request.

    Very
    truly yours,

    THARIMMUNE,
    INC.

    By:
    /s/
    Randy Milby

    Name:
    Randy
    Milby

    Title:
    Chief
    Executive Officer

    cc:

    Jeffrey
    Fessler, Sheppard Mullin Richter & Hampton LLP